LXU · Lsb Industries, Inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Oct 12, 2021; bars on opposite sides are not compared.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LXU
this stock
Lsb Industries, Inc.
|
$837.33M | +36.2% | +17.8% | 23.3 | 4.7% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$65.09B | +13.3% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$20.92B | +24.2% | -7.0% | — | 5.1% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$15.19B | +18.0% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.06B | +9.0% | -7.1% | — | 5.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Oct 12, 2021; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LXU | +3.1% | +17.3% | -21.0% | +8.5% | +36.2% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | +4.3% | +19.1% | -38.9% | +8.9% | +24.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.